ArticleCancers2024

Relationship of Immune-Related Adverse Events with Tumor Response and Prognosis in Esophageal Squamous Cell Carcinoma Following Nivolumab Monotherapy.

Yoichi Hamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.